Swathi Anipeddi is a Senior Pharmacovigilance Manager at Novo Nordisk, with over 12 years of experience in global drug safety and regulatory compliance. She has supported pharmacovigilance activities across multiple regions, contributing to the implementation and maintenance of global safety standards within diverse regulatory environments.

Her experience spans Africa, the Middle East, Central Asia, and Asia-Pacific, where she has been involved in overseeing pharmacovigilance operations across multiple countries, ensuring alignment with both global requirements and local regulations. She has worked extensively on pharmacovigilance systems oversight, vendor governance, and the management of outsourced safety activities.

Swathi has contributed to strengthening pharmacovigilance frameworks through structured oversight models, vendor lifecycle management, and support for inspection readiness and quality initiatives. She collaborates with cross-functional teams to support consistent and compliant safety processes across complex organizational settings.
She holds a Bachelor of Dental Sciences and has built her career in pharmacovigilance with a focus on operational effectiveness and regulatory compliance. Her professional interests include pharmacovigilance governance and advancing patient safety through collaborative and compliant practices.